Consequently, we evaluated if the assessment of the EGFR status in NSLC biopsies using an EGFR-specific PCR assay still has a place in the daily practice of an academic hospital center, and how this single gene testing approach could be integrated into lung cancer patient care. This evidence concerns the gene EGFR and lung carcinoma.